ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
ONCT
Delisted
ONCT was delisted on the 2nd of December, 2024.
43 hedge funds and large institutions have $2.48M invested in Oncternal Therapeutics, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 10 increasing their positions, 12 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
47% less capital invested
Capital invested by funds: $4.66M → $2.48M (-$2.18M)
Holders
43
Holding in Top 10
–
Calls
$61K
Puts
$52K
Top Buyers
| 1 | +$228K | |
| 2 | +$207K | |
| 3 | +$167K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$157K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$85K |
Top Sellers
| 1 | -$410K | |
| 2 | -$322K | |
| 3 | -$210K | |
| 4 |
VC
Vivo Capital
Palo Alto,
California
|
-$165K |
| 5 |
Millennium Management
New York
|
-$155K |